Delivery Order SPE2DB22D2206-SPE2DB25FFW31

Award Date 2/27/25
Potential Completion Date 3/20/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.66 firm fixed-price contract is for the supply of Envarsus XR 1 mg tablets, a specialty medication. The contract has a period of performance through February 25, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,615.33, is for the supply of Envarsus XR 4 mg tablets. The contract has a firm fixed price and has a ceiling value of $1,615.33. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,216.11 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of Envarsus XR 1 mg tablets. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, AmerisourceBergen provides a wide range of pharmaceutical products and medical supplies to support the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Envarsus XR 4 mg tablets. The contract has a ceiling value of $1,671.16 and a completion date of January 2, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,687.28 firm fixed-price contract is for the delivery of Envarsus XR 4 mg tablets, a transplant medication, to support military and federal healthcare programs. The contract has an ultimate completion date of August 21, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Envarsus XR 1 mg tablets. The Firm Fixed Price delivery order has a ceiling value of $1,216.11 and a period of performance through July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 1 mg tablets. The contract has a ceiling value of $1,621.48 and a performance period through August 13, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a broad range of pharmaceutical and medical products to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Envarsus XR 4 mg tablets, a pharmaceutical product. The contract has a ceiling value of $2,831.44 and an ultimate completion date of November 1, 2024. This is not a set-aside contract. Amerisourcebergen, a large pharmaceutical distributor, has been awarded numerous federal contracts to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,553.40, is a Firm Fixed Price Delivery Order for the supply of ENVARSUS XR 1 MG TABLET 30S medication. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,677.52 firm fixed-price contract is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFW31
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 1 mg tablets, a medication used in transplant patients. The contract has a ceiling value of $2,577.72 and runs through March 20, 2025. It is a firm-fixed-price contract, with no set-aside designation indicated.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/1/25, 3:11 AM